Company intelligence / Profile preview

Hallux Inc.

Laguna Hills, California, United Stateshalluxinc.com ↗

Ownership: Private
Development stage: Phase 2

Overview

Hallux is conducting a rigorous phase 2a efficacy, safety, and pharmacokinetics study evaluating once-monthly and once bi-monthly HSG applications over 44 weeks. The study is nearing completion as of the last update in the search results[1].

Therapeutic areas: Infectious Diseases
Modalities: Small molecules (terbinafine)
Industry: Biotech

Drug pipeline

2 assets

Terbinafine subungual gel

1 more asset in the full pipeline.

Request access →

Beyond the preview

Go deeper on Hallux Inc..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hallux Inc..

Explore the full profile